Transcriptional_JJ
repression_NN
of_IN
the_DT
interleukin-2_NN
gene_NN
by_IN
vitamin_NN
D3_NN
:_:
direct_JJ
inhibition_NN
of_IN
NFATp_NN
\/_:
AP-1_NN
complex_NN
formation_NN
by_IN
a_DT
nuclear_JJ
hormone_NN
receptor_NN
._.

T-lymphocyte_NN
proliferation_NN
is_VBZ
suppressed_VBN
by_IN
1,25-dihydroxyvitamin_NN
D3_NN
-LCB-_-LRB-
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
-RCB-_-RRB-
,_,
the_DT
active_JJ
metabolite_NN
of_IN
vitamin_NN
D3_NN
,_,
and_CC
is_VBZ
associated_VBN
with_IN
a_DT
decrease_NN
in_IN
interleukin_NN
2_CD
-LRB-_-LRB-
IL-2_NN
-RRB-_-RRB-
,_,
gamma_NN
interferon_NN
,_,
and_CC
granulocyte-macrophage_JJ
colony-stimulating_JJ
factor_NN
mRNA_NN
levels_NNS
._.

We_PRP
report_VBP
here_RB
that_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3-mediated_NN
repression_NN
in_IN
Jurkat_NN
cells_NNS
is_VBZ
cycloheximide_NN
resistant_JJ
,_,
suggesting_VBG
that_IN
it_PRP
is_VBZ
a_DT
direct_JJ
transcriptional_JJ
repressive_JJ
effect_NN
on_IN
IL-2_NN
expression_NN
by_IN
the_DT
vitamin_NN
D3_NN
receptor_NN
-LRB-_-LRB-
VDR_NN
-RRB-_-RRB-
._.

We_PRP
therefore_RB
examined_VBD
vitamin_NN
D3-mediated_JJ
repression_NN
of_IN
activated_VBN
IL-2_NN
expression_NN
by_IN
cotransfecting_VBG
Jurkat_NN
cells_NNS
with_IN
IL-2_NN
promoter_NN
\/_:
reporter_NN
constructs_NNS
and_CC
a_DT
VDR_NN
overexpression_NN
vector_NN
and_CC
by_IN
DNA_NN
binding_NN
._.

We_PRP
delineated_VBD
an_DT
element_NN
conferring_VBG
both_CC
DNA_NN
binding_NN
by_IN
the_DT
receptor_NN
in_FW
vitro_FW
and_CC
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3-mediated_JJ
repression_NN
in_FW
vivo_FW
to_TO
a_DT
short_JJ
40-bp_JJ
region_NN
encompassing_VBG
an_DT
important_JJ
positive_JJ
regulatory_JJ
element_NN
,_,
NF-AT-1_NN
,_,
which_WDT
is_VBZ
bound_VBN
by_IN
a_DT
T-cell-specific_JJ
transcription_NN
factor_NN
,_,
NFATp_NN
,_,
as_RB
well_RB
as_IN
by_IN
AP-1_NN
._.

VDR_NN
DNA-binding_JJ
mutants_NNS
were_VBD
unable_JJ
to_TO
either_CC
bind_VB
to_TO
this_DT
element_NN
in_FW
vitro_FW
or_CC
repress_VB
in_FW
vivo_FW
;_:
the_DT
VDR_NN
DNA-binding_JJ
domain_NN
alone_RB
,_,
however_RB
,_,
bound_VBD
the_DT
element_NN
but_CC
also_RB
could_MD
not_RB
repress_VB
IL-2_NN
expression_NN
._.

These_DT
results_NNS
indicate_VBP
that_IN
DNA_NN
binding_NN
by_IN
VDR_NN
is_VBZ
necessary_JJ
but_CC
not_RB
sufficient_JJ
to_TO
mediate_VB
IL-2_NN
repression_NN
._.

By_IN
combining_VBG
partially_RB
purified_VBN
proteins_NNS
in_FW
vitro_FW
,_,
we_PRP
observed_VBD
the_DT
loss_NN
of_IN
the_DT
bound_VBN
NFATp_NN
\/_:
AP-1-DNA_JJ
complex_NN
upon_IN
inclusion_NN
of_IN
VDR_NN
or_CC
VDR-retinoid_NN
X_NN
receptor_NN
._.

Order_NN
of_IN
addition_NN
and_CC
off-rate_JJ
experiments_NNS
indicate_VBP
that_IN
the_DT
VDR-retinoid_NN
X_NN
receptor_NN
heterodimer_NN
blocks_VBZ
NFATp_NN
\/_:
AP-1_NN
complex_NN
formation_NN
and_CC
then_RB
stably_RB
associates_VBZ
with_IN
the_DT
NF-AT-1_NN
element_NN
._.

This_DT
direct_JJ
inhibition_NN
by_IN
a_DT
nuclear_JJ
hormone_NN
receptor_NN
of_IN
transcriptional_JJ
activators_NNS
of_IN
the_DT
IL-2_NN
gene_NN
may_MD
provide_VB
a_DT
mechanistic_JJ
explanation_NN
of_IN
how_WRB
vitamin_NN
derivatives_NNS
can_MD
act_VB
as_IN
potent_JJ
immunosuppressive_JJ
agents_NNS
._.

